Switch to:
More From Other Websites
Activis CEO: Innovation vs. acquisition Jan 30 2015
The $25B GSK-Novartis deal clears major hurdle Jan 28 2015
Regulatory update on three-part transaction with Novartis Jan 28 2015
Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog Jan 28 2015
Why You Should — And Shouldn’t — Buy GlaxoSmithKline plc Jan 28 2015
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Jan 26 2015
GSK expands its portfolio of medicines in the US for patients with asthma and COPD Jan 26 2015
Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog Jan 23 2015
GSK-Parexel partnership takes first steps following layoffs announcement Jan 23 2015
Glaxo tackles fight against Ebola Jan 23 2015
Is GlaxoSmithKline plc’s Dividend About To Be Cut? Jan 21 2015
Africa's Consumer Economy Jan 21 2015
Stocks: Why earnings matter? Jan 20 2015
GlaxoSmithKline, plc (GSK): New Analyst Report from Zacks Equity Research - Zacks Equity Research... Jan 20 2015
OncoMed Starts Expansion Stage Study for Solid Tumor Drug - Analyst Blog Jan 16 2015
Why Now Is The Perfect Time To Buy GlaxoSmithKline plc Jan 16 2015
Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog Jan 15 2015
Vical Up on Deal with AnGes to Develop Ebola Treatment - Analyst Blog Jan 15 2015
5 Stunning Pharma Stocks: GlaxoSmithKline plc, AstraZeneca plc, Shire PLC, BTG plc & Hikma... Jan 13 2015
More Rotavirus Vaccination Means Less Rotavirus Jan 12 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK